ANTONIOLI, ELISABETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.438
EU - Europa 2.140
AS - Asia 286
OC - Oceania 2
SA - Sud America 2
Totale 4.868
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.435
PL - Polonia 1.172
SE - Svezia 227
IT - Italia 206
IE - Irlanda 192
CN - Cina 86
RU - Federazione Russa 71
DE - Germania 70
HK - Hong Kong 68
UA - Ucraina 67
FI - Finlandia 44
CH - Svizzera 31
GB - Regno Unito 31
SG - Singapore 29
JO - Giordania 27
KR - Corea 21
TR - Turchia 21
VN - Vietnam 17
FR - Francia 15
IN - India 10
BE - Belgio 8
AE - Emirati Arabi Uniti 5
CA - Canada 3
EC - Ecuador 2
NL - Olanda 2
AT - Austria 1
AU - Australia 1
BY - Bielorussia 1
LT - Lituania 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 4.868
Salva come PNG Salva come JPEG
Città #
Warsaw 1.172
Fairfield 429
Chandler 232
Dublin 190
Seattle 174
Ashburn 173
Woodbridge 168
Cambridge 160
Houston 156
Wilmington 145
Jacksonville 126
Ann Arbor 83
Lawrence 59
Altamura 57
Princeton 47
Beijing 46
Boston 36
New York 36
Hong Kong 33
Bern 31
Boardman 31
San Diego 30
Buffalo 25
Seoul 21
Medford 19
Izmir 16
Shanghai 16
Singapore 16
Bremen 14
Dong Ket 13
Salerno 13
Moscow 12
Andover 11
Florence 11
Falls Church 9
Naples 9
Norwalk 9
Rome 9
Brussels 8
Los Angeles 8
Phoenix 8
Milan 7
Helsinki 6
London 6
Pune 6
Redwood City 6
Abu Dhabi 5
Cagliari 4
Hillsboro 4
Kent 4
Pisa 4
Cecina 3
Delhi 3
Jena 3
Lomazzo 3
Noicattaro 3
Prato 3
Quartu Sant'Elena 3
Siena 3
Toronto 3
Acton 2
Auburn Hills 2
Augusta 2
Bari 2
Beilngries 2
Dearborn 2
Farra di Soligo 2
Frankfurt Am Main 2
Guayaquil 2
Hangzhou 2
Hebei 2
Hounslow 2
Jiaxing 2
Miles 2
Mountain View 2
Nanchang 2
Paris 2
Romainville 2
San Mateo 2
Shaoxing 2
Treviso 2
Turin 2
Vinci 2
West Jordan 2
Angeles City 1
Auckland 1
Bratislava 1
Brindisi 1
Buccinasco 1
Canaan 1
Cantagallo 1
Carrara 1
Catania 1
Chennai 1
Cinisello Balsamo 1
Dallas 1
Fuzhou 1
Greystones 1
Ivrea 1
Kilcock 1
Totale 4.004
Salva come PNG Salva come JPEG
Nome #
Hydroxyurea does not appreciably reduce JAK2 V617F allele burden in patients with polycythemia vera or essential thrombocythemia. 252
Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allele. 249
Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis:an international study. 246
Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms. 237
JAK2V617F mutational status and allele burden have little influence on clinical phenotype and prognosis in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis 233
Frequency and clinical correlates of JAK2 46/1 (GGCC) haplotype in primary myelofibrosis. 230
Polycythemia vera following autologous transplantation for AML: insights on the kinetics of JAK2V617F clonal dominance. 222
Thrombocytosis and leukocytosis interactions in vascular complications of essential thrombocythemia 207
Nuovi target terapeutici nelle malattie mieloproliferativa croniche Ph negative 192
B-, T-, and NK-cell lineage involvement in JAK2V617F-positive patients with idiopathic myelofibrosis. 152
Leukocytosis and risk stratification assessment in essential thrombocythemia. 104
MicroRNA expression profile in granulocytes from primary myelofibrosis patients. 103
Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia. 98
Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia. 98
Treatment options for essential thrombocythemia and polycythemia vera 98
Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal. 96
Thrombosis in primary myelofibrosis: incidence and risk factors. 94
JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis. 93
Hydroxyurea in essential thrombocythemia: rate and clinical relevance of responses by European LeukemiaNet criteria. 90
Chemotherapy-related nail toxicity 88
Daratumumab, lenalidomide, and dexamethasone combination in relapsed/refractory myeloma patients: a real-life single-center experience 87
Clinical implications of the JAK2 V617F mutation in essential thrombocythemia. 86
Risk of second cancers in chronic myeloproliferative neoplasms. 84
Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria. 82
Autologous stem cell transplantation is safe in selected elderly multiple myeloma patients 81
Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria. 79
Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia. 79
Inconsistencies in the association between the JAL2V617F mutation and PRV-1 over-expression among the chronic myeloproliferative diseases 78
JAK2V617F allele burden and thrombosis: a direct comparison in Essential Thrombocythemia and Polycythemia Vera 77
Prospective identification of high-risk polycythemia vera patients based on JAK2(V617F) allele burden. 76
Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis 74
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN 73
Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: a retrospective survey. 73
Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3. 70
Mastocitosi: approccio multidisciplinare a una patologia misconoscciuta 70
No role for CXCL12-G801A polymorphism in the development of extramedullary disease in acute myeloid leukemia. 69
Risk of second cancers in chronic myeloproliferative neoplasms 68
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients. 62
Leukocytosis as an important risk factor for arterial thrombosis in WHO-defined early/prefibrotic myelofibrosis: An international study of 264 patients. 59
Anaemia characterises patients with myelofibrosis harbouring Mpl mutation. 57
Aggressive Disease Course of Multiple Myeloma with Concomitant ALK-Negative Anaplastic Large Cell Lymphoma: A Case Report with an Unusual Presentation 53
Incidence of light chain amyloidosis in Florence metropolitan area, Italy: a population-based study 38
Percorsi diagnostici-terapeutici per le neoplasie mieloproliferative nella AOU Careggi 36
Ninety-Minute Daratumumab Infusions for Relapsed and Refractory Multiple Myeloma: Two Years of Italian Single-Center Observational Study 34
Lenalidomide: A double-edged sword for concomitant multiple myeloma and post-essential thrombocythemia myelofibrosis 34
A multidisciplinary case report of multiple myeloma with renal and cardiac involvement: a look beyond amyloidosis 27
Ventricular tachyarrhythmias and sudden cardiac death in light-chain amyloidosis: a clash of cardio-toxicities? 21
Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma Network 11
Totale 4.920
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.500
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.500
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.129 0 106 29 105 137 147 124 152 117 71 124 17
2020/2021688 78 62 49 67 31 73 26 62 61 84 41 54
2021/2022367 7 58 22 9 11 18 22 20 13 13 76 98
2022/2023974 88 174 47 98 76 157 116 58 89 7 28 36
2023/2024371 16 43 53 18 24 78 8 61 9 20 32 9
2024/2025102 67 35 0 0 0 0 0 0 0 0 0 0
Totale 4.920